{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:14:22Z","timestamp":1784247262063,"version":"3.55.0"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1124\/jpet.112.202036","type":"journal-article","created":{"date-parts":[[2013,4,17]],"date-time":"2013-04-17T05:21:20Z","timestamp":1366176080000},"page":"138-145","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Melatonin and Its Analog 5-Methoxycarbonylamino-N-Acetyltryptamine Potentiate Adrenergic Receptor-Mediated Ocular Hypotensive Effects in Rabbits: Significance for Combination Therapy in Glaucoma"],"prefix":"10.1016","volume":"346","author":[{"given":"Almudena","family":"Crooke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Huete-Toral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Mart\u00ednez-\u00c1guila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Mart\u00edn-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Pintor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.112.202036_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00002512-199812030-00005","article-title":"Brimonidine. A review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension","volume":"12","author":"Adkins","year":"1998","journal-title":"Drugs Aging"},{"key":"10.1124\/jpet.112.202036_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1600-079X.2010.00816.x","article-title":"The role of melatonin in glaucoma: implications concerning pathophysiological relevance and therapeutic potential","volume":"50","author":"Agorastos","year":"2011","journal-title":"J Pineal Res"},{"key":"10.1124\/jpet.112.202036_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/sj.eye.6701428","article-title":"Comparison of additional intraocular pressure-lowering effects of latanoprost vs brimonidine in primary open-angle glaucoma patients with intraocular pressure uncontrolled by timolol-dorzolamide combination","volume":"19","author":"Akman","year":"2005","journal-title":"Eye (Lond)"},{"key":"10.1124\/jpet.112.202036_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.autneu.2007.07.004","article-title":"Requirement of intact sympathetic transmission for the ocular hypotensive effects of melatonin and 5-MCA-NAT","volume":"137","author":"Alarma-Estrany","year":"2007","journal-title":"Auton Neurosci"},{"key":"10.1124\/jpet.112.202036_bib5","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1600-079X.2009.00702.x","article-title":"5-MCA-NAT does not act through NQO2 to reduce intraocular pressure in New-Zealand white rabbit","volume":"47","author":"Alarma-Estrany","year":"2009","journal-title":"J Pineal Res"},{"key":"10.1124\/jpet.112.202036_bib6","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1124\/jpet.110.178319","article-title":"Design of novel melatonin analogs for the reduction of intraocular pressure in normotensive rabbits","volume":"337","author":"Alarma-Estrany","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/jpet.112.202036_bib7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/j.1600-079X.2008.00618.x","article-title":"Sympathetic nervous system modulates the ocular hypotensive action of MT2-melatonin receptors in normotensive rabbits","volume":"45","author":"Alarma-Estrany","year":"2008","journal-title":"J Pineal Res"},{"key":"10.1124\/jpet.112.202036_bib8","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.exer.2008.12.012","article-title":"Uveoscleral outflow\u2014a review","volume":"88","author":"Alm","year":"2009","journal-title":"Exp Eye Res"},{"key":"10.1124\/jpet.112.202036_bib9","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.preteyeres.2011.11.002","article-title":"The molecular basis of retinal ganglion cell death in glaucoma","volume":"31","author":"Almasieh","year":"2012","journal-title":"Prog Retin Eye Res"},{"key":"10.1124\/jpet.112.202036_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1515\/REVNEURO.2004.15.3.209","article-title":"Genetic aspects of melatonin biology","volume":"15","author":"Anisimov","year":"2004","journal-title":"Rev Neurosci"},{"key":"10.1124\/jpet.112.202036_bib11","first-page":"1189","article-title":"Pharmacological effects of topical timolol in the rabbit eye","volume":"19","author":"Bartels","year":"1980","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/jpet.112.202036_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1600-079X.2010.00762.x","article-title":"Melatonin: a novel neuroprotectant for the treatment of glaucoma","volume":"48","author":"Belforte","year":"2010","journal-title":"J Pineal Res"},{"key":"10.1124\/jpet.112.202036_bib13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1042\/bj3470643","article-title":"Differential adrenergic regulation of the gene expression of the beta-adrenoceptor subtypes beta1, beta2 and beta3 in brown adipocytes","volume":"347","author":"Bengtsson","year":"2000","journal-title":"Biochem J"},{"key":"10.1124\/jpet.112.202036_bib14","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.exer.2003.09.021","article-title":"The ins and outs of aqueous humour secretion","volume":"78","author":"Civan","year":"2004","journal-title":"Exp Eye Res"},{"issue":"1 Suppl","key":"10.1124\/jpet.112.202036_bib15","first-page":"25","article-title":"ImageJ for microscopy","volume":"43","author":"Collins","year":"2007","journal-title":"Biotechniques"},{"key":"10.1124\/jpet.112.202036_bib16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1124\/mol.51.4.551","article-title":"Regulation of pineal alpha1B-adrenergic receptor mRNA: day\/night rhythm and beta-adrenergic receptor\/cyclic AMP control","volume":"51","author":"Coon","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1124\/jpet.112.202036_bib17","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ajo.2011.06.015","article-title":"Clinical evidence for neuroprotection in glaucoma","volume":"152","author":"Cordeiro","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1124\/jpet.112.202036_bib18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1089\/108076802760116142","article-title":"Adenylyl cyclase activity mediated by beta-adrenoceptors in immortalized human trabecular meshwork and non-pigmented ciliary epithelial cells","volume":"18","author":"Crider","year":"2002","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1124\/jpet.112.202036_bib19","doi-asserted-by":"crossref","first-page":"3508","DOI":"10.2174\/092986712801323234","article-title":"Update in glaucoma medicinal chemistry: emerging evidence for the importance of melatonin analogues","volume":"19","author":"Crooke","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1124\/jpet.112.202036_bib20","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1097\/FPC.0b013e32834910d1","article-title":"Regulation of ocular adrenoceptor genes expression by 5-MCA-NAT: implications for glaucoma treatment","volume":"21","author":"Crooke","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/jpet.112.202036_bib21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1600-079X.2011.00938.x","article-title":"Involvement of carbonic anhydrases in the ocular hypotensive effect of melatonin analogue 5-MCA-NAT","volume":"52","author":"Crooke","year":"2012","journal-title":"J Pineal Res"},{"key":"10.1124\/jpet.112.202036_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exer.2012.11.007","article-title":"Melatonin receptor agonist-induced reduction of SNP-released nitric oxide and cGMP production in isolated human non-pigmented ciliary epithelial cells","volume":"107","author":"Dortch-Carnes","year":"2013","journal-title":"Exp Eye Res"},{"key":"10.1124\/jpet.112.202036_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1358\/dnp.2006.19.3.985929","article-title":"Trabecular meshwork as a new target for the treatment of glaucoma","volume":"19","author":"Ferrer","year":"2006","journal-title":"Drug News Perspect"},{"key":"10.1124\/jpet.112.202036_bib24","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1096\/fj.08-121467","article-title":"Egr1 involvement in evening gene regulation by melatonin","volume":"23","author":"Fustin","year":"2009","journal-title":"FASEB J"},{"key":"10.1124\/jpet.112.202036_bib25","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1167\/iovs.07-1056","article-title":"Pentacam tomograms: a novel method for quantification of posterior capsule opacification","volume":"49","author":"Grewal","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/jpet.112.202036_bib26","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1016\/S0149-2918(00)80008-9","article-title":"Comparison of dorzolamide and pilocarpine as adjunctive therapy in patients with open-angle glaucoma and ocular hypertension","volume":"21","author":"Hartenbaum","year":"1999","journal-title":"Clin Ther"},{"key":"10.1124\/jpet.112.202036_bib27","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1136\/bjo.82.11.1249","article-title":"Comparison of the safety and efficacy of the fixed combination of dorzolamide\/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study","volume":"82","author":"Hutzelmann","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1124\/jpet.112.202036_bib28","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1213\/ane.0b013e3181907ebe","article-title":"Melatonin provides anxiolysis, enhances analgesia, decreases intraocular pressure, and promotes better operating conditions during cataract surgery under topical anesthesia","volume":"108","author":"Ismail","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1124\/jpet.112.202036_bib29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1034\/j.1600-0420.2003.00097.x","article-title":"Timolol 0.5%\/dorzolamide 2% fixed combination versus timolol 0.5%\/pilocarpine 2% fixed combination in primary open-angle glaucoma or ocular hypertensive patients","volume":"81","author":"Ka\u0142uzny","year":"2003","journal-title":"Acta Ophthalmol Scand"},{"key":"10.1124\/jpet.112.202036_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2012.04.040","article-title":"Gene regulation by melatonin linked to epigenetic phenomena","volume":"503","author":"Korkmaz","year":"2012","journal-title":"Gene"},{"key":"10.1124\/jpet.112.202036_bib31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ajo.2010.09.026","article-title":"A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study","volume":"151","author":"Krupin","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1124\/jpet.112.202036_bib32","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.107.153676","article-title":"Calcium cycling protein density and functional importance to automaticity of isolated sinoatrial nodal cells are independent of cell size","volume":"100","author":"Lyashkov","year":"2007","journal-title":"Circ Res"},{"key":"10.1124\/jpet.112.202036_bib33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ejphar.2012.12.009","article-title":"Melatonin analogue agomelatine reduces rabbit's intraocular pressure in normotensive and hypertensive conditions","volume":"701","author":"Martinez-Aguila","year":"2013","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.112.202036_bib34","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1007\/PL00012498","article-title":"Melatonin regulation of antioxidant enzyme gene expression","volume":"59","author":"Mayo","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/jpet.112.202036_bib35","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.exer.2008.10.018","article-title":"Measurement of aqueous humor flow","volume":"88","author":"McLaren","year":"2009","journal-title":"Exp Eye Res"},{"key":"10.1124\/jpet.112.202036_bib36","doi-asserted-by":"crossref","first-page":"4923","DOI":"10.1210\/en.2003-0537","article-title":"Direct effects of testosterone, 17 beta-estradiol, and progesterone on adrenergic regulation in cultured brown adipocytes: potential mechanism for gender-dependent thermogenesis","volume":"144","author":"Monjo","year":"2003","journal-title":"Endocrinology"},{"key":"10.1124\/jpet.112.202036_bib37","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1096\/fj.04-3313fje","article-title":"Effect of glaucoma on the retinal glutamate\/glutamine cycle activity","volume":"19","author":"Moreno","year":"2005","journal-title":"FASEB J"},{"key":"10.1124\/jpet.112.202036_bib38","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1023\/A:1008688724058","article-title":"Melatonin and its physiological and therapeutic properties","volume":"20","author":"Nowak","year":"1998","journal-title":"Pharm World Sci"},{"key":"10.1124\/jpet.112.202036_bib39","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0002-9394(01)01257-0","article-title":"Evaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%","volume":"132","author":"Orengo-Nania","year":"2001","journal-title":"Am J Ophthalmol"},{"key":"10.1124\/jpet.112.202036_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/exer.1994.1076","article-title":"The presence of functional melatonin receptors in the iris-ciliary processes of the rabbit eye","volume":"59","author":"Osborne","year":"1994","journal-title":"Exp Eye Res"},{"key":"10.1124\/jpet.112.202036_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.phrs.2012.03.002","article-title":"Protecting the retinal neurons from glaucoma: lowering ocular pressure is not enough","volume":"66","author":"Pascale","year":"2012","journal-title":"Pharmacol Res"},{"key":"10.1124\/jpet.112.202036_bib42","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1442-9071.2011.02573.x","article-title":"Prevention of retinal ganglion cell swelling by systemic brimonidine in a rat experimental glaucoma model","volume":"39","author":"Pinar-Sueiro","year":"2011","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1124\/jpet.112.202036_bib43","doi-asserted-by":"crossref","unstructured":"Pintor J (2009) Autonomic nervous system: ophthalmic control, in Encyclopedia of Neuroscience (Squire LR ed) pp 967\u2013974, Academic Press, Oxford.","DOI":"10.1016\/B978-008045046-9.00639-2"},{"key":"10.1124\/jpet.112.202036_bib44","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0014-2999(01)00864-0","article-title":"Involvement of melatonin MT(3) receptors in the regulation of intraocular pressure in rabbits","volume":"416","author":"Pintor","year":"2001","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/jpet.112.202036_bib45","unstructured":"Pintor J, Martinez-Aguila A, and Bergua A (2011), inventors. Use of melatonin analogues for the reduction of the intraocular pressure. International patent P201101173. 2011 Oct 28."},{"key":"10.1124\/jpet.112.202036_bib46","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/sj.bjp.0705118","article-title":"Ocular hypotensive effects of melatonin receptor agonists in the rabbit: further evidence for an MT3 receptor","volume":"138","author":"Pintor","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/jpet.112.202036_bib47","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","article-title":"Glaucoma","volume":"377","author":"Quigley","year":"2011","journal-title":"Lancet"},{"key":"10.1124\/jpet.112.202036_bib48","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.clinthera.2006.04.007","article-title":"A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension","volume":"28","author":"Reis","year":"2006","journal-title":"Clin Ther"},{"key":"10.1124\/jpet.112.202036_bib49","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.exer.2005.07.015","article-title":"\u03b12 adrenergic agonist on ciliary blood flow and aqueous production in rabbits","volume":"82","author":"Reitsamer","year":"2006","journal-title":"Exp Eye Res"},{"key":"10.1124\/jpet.112.202036_bib50","first-page":"1","article-title":"Melatonin as a therapeutic tool in ophthalmology: implications for glaucoma and uveitis","volume":"49","author":"Rosenstein","year":"2010","journal-title":"J Pineal Res"},{"key":"10.1124\/jpet.112.202036_bib51","doi-asserted-by":"crossref","first-page":"169","DOI":"10.3109\/02713688109001822","article-title":"Circadian rhythm in intraocular pressure: a rabbit model","volume":"1","author":"Rowland","year":"1981","journal-title":"Curr Eye Res"},{"key":"10.1124\/jpet.112.202036_bib52","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.ijg.0000133150.44686.0b","article-title":"Effect of 5-MCA-NAT, a putative melatonin MT3 receptor agonist, on intraocular pressure in glaucomatous monkey eyes","volume":"13","author":"Serle","year":"2004","journal-title":"J Glaucoma"},{"key":"10.1124\/jpet.112.202036_bib53","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1080\/02713680701434899","article-title":"Primary culture of porcine nonpigmented ciliary epithelium","volume":"32","author":"Shahidullah","year":"2007","journal-title":"Curr Eye Res"},{"key":"10.1124\/jpet.112.202036_bib54","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1089\/108076801753162726","article-title":"Levobetaxolol (Betaxon) and other beta-adrenergic antagonists: preclinical pharmacology, IOP-lowering activity and sites of action in human eyes","volume":"17","author":"Sharif","year":"2001","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1124\/jpet.112.202036_bib55","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/S0149-2918(01)80064-3","article-title":"Efficacy of brimonidine 0.2% and dorzolamide 2% as adjunctive therapy to beta-blockers in adult patients with glaucoma or ocular hypertension","volume":"23","author":"Simmons","year":"2001","journal-title":"Clin Ther"},{"key":"10.1124\/jpet.112.202036_bib56","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-079X.2005.00304.x","article-title":"Protective effects of melatonin in experimental free radical-related ocular diseases","volume":"40","author":"Siu","year":"2006","journal-title":"J Pineal Res"},{"key":"10.1124\/jpet.112.202036_bib57","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1600-079X.1999.tb00606.x","article-title":"Pineal indoleamines and vitamin E reduce nitric oxide-induced lipid peroxidation in rat retinal homogenates","volume":"27","author":"Siu","year":"1999","journal-title":"J Pineal Res"},{"key":"10.1124\/jpet.112.202036_bib58","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/00061198-200404000-00012","article-title":"Dorzolamide\/Timolol fixed combination versus concomitant administration of brimonidine and timolol in patients with elevated intraocular pressure: a 3-month comparison of efficacy, tolerability, and patient-reported measures","volume":"13","author":"Solish","year":"2004","journal-title":"J Glaucoma"},{"key":"10.1124\/jpet.112.202036_bib59","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1556\/APhysiol.98.2011.4.6","article-title":"Regulation of atrial catecholamine enzymes and adrenoceptor gene expression after chronic stress","volume":"98","author":"Spasojevic","year":"2011","journal-title":"Acta Physiol Hung"},{"key":"10.1124\/jpet.112.202036_bib60","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/S0002-9394(99)00237-8","article-title":"Efficacy and safety of timolol solution once daily vs timolol gel added to latanoprost","volume":"128","author":"Stewart","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"10.1124\/jpet.112.202036_bib61","first-page":"987","article-title":"Comparison of the effects of timolol and other adrenergic agents on intraocular pressure in the rabbit","volume":"16","author":"Vareilles","year":"1977","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1124\/jpet.112.202036_bib62","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-079X.2010.00746.x","article-title":"Molecular and cellular pharmacological properties of 5-methoxycarbonylamino-N-acetyltryptamine (MCA-NAT): a nonspecific MT3 ligand","volume":"48","author":"Vincent","year":"2010","journal-title":"J Pineal Res"},{"key":"10.1124\/jpet.112.202036_bib63","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1073\/pnas.81.17.5599","article-title":"Adenosine strongly potentiates pressor responses to nicotine in rats","volume":"81","author":"von Borstel","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/jpet.112.202036_bib64","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/0024-3205(83)90121-2","article-title":"Chronic caffeine consumption potentiates the hypotensive action of circulating adenosine","volume":"32","author":"von Borstel","year":"1983","journal-title":"Life Sci"},{"key":"10.1124\/jpet.112.202036_bib65","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2165\/00002512-200825090-00002","article-title":"Pharmacological management of primary open-angle glaucoma: second-line options and beyond","volume":"25","author":"Webers","year":"2008","journal-title":"Drugs Aging"},{"issue":"Suppl 1","key":"10.1124\/jpet.112.202036_bib66","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/S0039-6257(03)00004-3","article-title":"Role of alpha-2 agonists in neuroprotection","volume":"48","author":"Wheeler","year":"2003","journal-title":"Surv Ophthalmol"},{"key":"10.1124\/jpet.112.202036_bib67","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1006\/exer.2001.1073","article-title":"Melatonin receptor mRNA and protein expression in Xenopus laevis nonpigmented ciliary epithelial cells","volume":"73","author":"Wiechmann","year":"2001","journal-title":"Exp Eye Res"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524186430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524186430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.112.202036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T17:23:02Z","timestamp":1739985782000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524186430"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0022356524186430"],"URL":"https:\/\/doi.org\/10.1124\/jpet.112.202036","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melatonin and Its Analog 5-Methoxycarbonylamino-N-Acetyltryptamine Potentiate Adrenergic Receptor-Mediated Ocular Hypotensive Effects in Rabbits: Significance for Combination Therapy in Glaucoma","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.112.202036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2013 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}